Saxena Nishant C
Chief Business Officer
Saxena Nishant C has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Saxena Nishant C is listed as Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Saxena Nishant C reported 3 open-market purchases totaling $126K in CRBP and no open-market sales. The largest disclosed transaction in the window is a purchase of 9,000 CRBP shares on Jun 3, 2026, worth $68K.
Companies traded
Other insiders at CRBP
Insider Buying
$126K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Saxena Nishant C made?
Saxena Nishant C has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Saxena Nishant C trade?
Saxena Nishant C has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Saxena Nishant C's most recent SEC Form 4 filing?
Saxena Nishant C's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Saxena Nishant C's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Saxena Nishant C is listed as Chief Business Officer.
What is Saxena Nishant C's total buy and sell value in the current window?
Inside the rolling retention window, Saxena Nishant C bought $126K and sold $0 based on SEC Form 4 filings.
What was Saxena Nishant C's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 9,000 CRBP shares on 2026-06-03, worth $68K, per SEC Form 4 filings.